231 related articles for article (PubMed ID: 25638159)
21. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.
Vleeshouwers W; van den Dries K; de Keijzer S; Joosten B; Lidke DS; Cambi A
Front Immunol; 2020; 11():613286. PubMed ID: 33643295
[TBL] [Abstract][Full Text] [Related]
22. Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Woo SM; Min KJ; Chae IG; Chun KS; Kwon TK
Mol Carcinog; 2015 Mar; 54(3):216-28. PubMed ID: 24127286
[TBL] [Abstract][Full Text] [Related]
23. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
24. Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle.
Huang N; Liu B; Dong Z; Mao W; Zhang N; Li C; Cao J
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):170-5. PubMed ID: 26319698
[TBL] [Abstract][Full Text] [Related]
25. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
Arosh JA; Lee J; Balasubbramanian D; Stanley JA; Long CR; Meagher MW; Osteen KG; Bruner-Tran KL; Burghardt RC; Starzinski-Powitz A; Banu SK
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9716-21. PubMed ID: 26199416
[TBL] [Abstract][Full Text] [Related]
26. The Gαs-protein-mediated pathway may be steadily stimulated by prostanoid EP2 receptors, but not by EP4 receptors.
Fukushima K; Senoo K; Kurata N; Regan JW; Fujino H
FEBS Open Bio; 2022 Apr; 12(4):775-783. PubMed ID: 35124898
[TBL] [Abstract][Full Text] [Related]
27. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.
Li RC; Cindrova-Davies T; Skepper JN; Sellers LA
Circ Res; 2004 Apr; 94(6):759-67. PubMed ID: 14963006
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E2 blockade enhances the pulmonary anti-Cryptococcus neoformans immune reaction via the induction of TLR-4.
Shen L; Liu Y
Int Immunopharmacol; 2015 Sep; 28(1):376-81. PubMed ID: 26122137
[TBL] [Abstract][Full Text] [Related]
29. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
[TBL] [Abstract][Full Text] [Related]
30. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
Chen Y; Tang Q; Xiao Q; Yang L; Hann SS
J Cell Mol Med; 2017 Feb; 21(2):222-233. PubMed ID: 27620163
[TBL] [Abstract][Full Text] [Related]
31. The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice.
Takahashi T; Ogawa H; Izumi K; Uehara H
Cancer Lett; 2011 Jul; 306(1):67-75. PubMed ID: 21419570
[TBL] [Abstract][Full Text] [Related]
32. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
33. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.
Fujino H; Salvi S; Regan JW
Mol Pharmacol; 2005 Jul; 68(1):251-9. PubMed ID: 15855407
[TBL] [Abstract][Full Text] [Related]
35. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure.
Echeverria V; Clerman A; Doré S
Eur J Neurosci; 2005 Nov; 22(9):2199-206. PubMed ID: 16262658
[TBL] [Abstract][Full Text] [Related]
37. Characterization of prostaglandin E2 receptors (EP2, EP4) in the horse oviduct.
Ball BA; Scoggin KE; Troedsson MH; Squires EL
Anim Reprod Sci; 2013 Nov; 142(1-2):35-41. PubMed ID: 24035156
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
[TBL] [Abstract][Full Text] [Related]
39. Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines.
Peng L; Ye Y; Mullikin H; Lin L; Kuhn C; Rahmeh M; Mahner S; Jeschke U; von Schönfeldt V
J Reprod Immunol; 2020 Nov; 142():103210. PubMed ID: 33011635
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
Fan Y; Wang Y; Wang K
Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
